A randomized, clinical trial to assess the relative efficacy and tolerability of two doses of etoricoxib versus naproxen in patients with ankylosing spondylitis
Crossref DOI link: https://doi.org/10.1186/s12891-016-1275-5
Published Online: 2016-10-13
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Balazcs, Eva
Sieper, Joachim
Bickham, Kara
Mehta, Anish
Frontera, Nancy
Stryszak, Paul
Popmihajlov, Zoran
Peloso, Paul M.
Funding for this research was provided by:
Merck